Cell Genesys' Saving Grace
Forbes
Wed, 08/27/08 - 10:30 pm
Takeda's Velcade Found Better Than Standard Blood-Cancer Drug
Bloomberg
Wed, 08/27/08 - 10:28 pm
Efficacy Questions Still Dog Vytorin
Forbes
Wed, 08/27/08 - 10:27 pm
Rough Road Ahead For Byetta
Forbes
Wed, 08/27/08 - 10:24 pm
Vioxx settlement judge caps legal fees at 32 pct
Yahoo/AP
Wed, 08/27/08 - 04:41 pm
King Pharma a Hold, Pre-Acquisition
Yahoo/Zacks.com
Wed, 08/27/08 - 04:26 pm
Grim Reaper Hurts Cell Genesys
Forbes
Wed, 08/27/08 - 04:25 pm
Another Storm Brewing For Vytorin
Forbes
Wed, 08/27/08 - 04:23 pm
Amylin, Lilly: Another Case of a Panic Driven Sell-Off
Seeking Alpha
Wed, 08/27/08 - 04:20 pm
Bad News Byetta
Forbes
Wed, 08/27/08 - 04:19 pm
NexMed shares nosedive as partner Novartis nixes plan to file for approval of treatment
Yahoo/AP
Wed, 08/27/08 - 04:17 pm
Bristol-Myers shares dip on failed drug study
Yahoo/AP
Wed, 08/27/08 - 04:16 pm
Teva Tells It Like It Is
Motley Fool
Wed, 08/27/08 - 04:14 pm
Pills and Politics: The normally GOP-friendly drug industry now favors Obama
Slate
Wed, 08/27/08 - 12:03 pm
When it rains risk it pours; within a 12-hour period five biopharma companies revealed negative drug news that is sending their stocks lower
CNBC
Wed, 08/27/08 - 12:00 pm
Drug maker Schering-Plough wins EU OK to sell animal medicines to rival Pfizer
Yahoo/AP
Wed, 08/27/08 - 11:56 am
Will hostile takeovers become the norm for drugmakers?
Bizmology
Wed, 08/27/08 - 10:15 am
Amylin Tumbles After Four More Patients Die While Using Byetta
Bloomberg
Wed, 08/27/08 - 10:01 am
The Early Edge: Amylin Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly, and Pfizer
Schaeffer's Research
Wed, 08/27/08 - 10:00 am
A Failure Makes Bristol’s Deal With Pfizer Look Smart
WSJ Online
Wed, 08/27/08 - 08:48 am

Pages